Condensed Consolidated Statements of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Net cash provided by operating activities	$ 64,015	$ 101,063
Cash flows from investing activities:
Sale of investment securities	28,102	16,140
Purchase of investment securities	(2,847)	(9,394)
Proceeds from sale or liquidation of long-term investments	66,190	1,106
Purchase of long-term investments	(10,000)	(5,062)
Investments in non-consolidated real estate businesses	(7,201)	(4,033)
Purchase of Aberdeen mortgages	0	(13,462)
Distributions from non-consolidated real estate businesses	6,752	3,539
Proceeds from sale of townhome, net	19,629	0
Increase in cash surrender value of life insurance policies	(717)	(918)
Decrease in restricted assets	738	384
Issuance of notes receivable	(216)	(720)
Cash acquired in Aberdeen consolidation	0	473
Proceeds from sale of fixed assets	156	187
Capital expenditures	(8,469)	(15,730)
Net cash provided by (used in) investing activities	92,117	(27,490)
Cash flows from financing activities:
Proceeds from debt issuance	2,823	89,373
Deferred financing costs	0	(2,582)
Repayments of debt	(3,522)	(7,175)
Borrowings under revolver	769,247	732,708
Repayments on revolver	(804,957)	(750,091)
Dividends and distributions on common stock	(92,987)	(87,797)
Proceeds from exercise of employee stock options	1,029	980
Tax benefit of employee stock options exercised	821	121
Net cash used in financing activities	(127,546)	(24,463)
Net increase in cash and cash equivalents	28,586	49,110
Cash and cash equivalents, beginning of period	299,825	209,454
Cash and cash equivalents, end of period	$ 328,411	$ 258,564